ATI Inc. SEC filings document the reporting record for a NYSE-listed producer of high-performance materials, specialty alloys, components, and related solutions for aerospace and defense, specialty energy, electronics, medical, and other industrial applications. The filings identify the company's common stock, operating disclosures, segment-related performance measures, and risk and governance matters.
ATI's filings include Form 8-K reports for quarterly and annual operating results, share repurchase authorization, executive and board leadership matters, and material financing agreements, including an accounts receivable securitization facility involving ATI Specialty Materials. Proxy materials provide formal disclosure on director elections, executive compensation, shareholder voting matters, board structure, and corporate governance policies.
ATI Inc. is planning an underwritten public offering of a new series of seven-year senior notes, subject to market and other conditions. The company intends to use the net proceeds primarily to redeem all of its outstanding 5.875% Senior Notes due 2027, with any remainder earmarked for general corporate purposes. The notes will be issued under an effective shelf registration statement, with Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC acting as joint book-running managers and co-global coordinators.
ATI Inc. is offering senior unsecured notes under a preliminary prospectus supplement to refinance its outstanding 5.875% Senior Notes due 2027. The offering’s net proceeds are intended to fund a redemption of the $350.0 million aggregate principal amount of the 2027 Notes.
The notes will be senior unsecured obligations, will rank equally with existing and future senior unsecured indebtedness and will be structurally subordinated to subsidiary liabilities; subsidiaries will not initially guarantee the notes. The notes include an optional redemption schedule and a Change of Control Repurchase Event requiring an offer to repurchase at 101% of principal under specified ratings conditions.
ATI Inc. filed a Form 144 reporting a proposed sale of 40,500 shares of Common Stock. The filing lists multiple restricted stock unit grants acquired as compensation on various dates, including 10,389 shares (05/17/2023) and 7,704 shares (05/16/2024).
The securities are noted as issuer‑granted restricted stock units and the broker listed is Goldman Sachs & Co. LLC. The filing lists grant dates and share counts for individual RSU lots; timing and proceeds treatment are not detailed in the excerpt provided.
Filer submitted a Form 144 disclosing a proposed sale of 59,749 shares of Common Stock tied to restricted stock vesting dated 01/05/2026. The filing shows a prior disposition of 40,000 shares reported on 05/11/2026 with an indicated proceeds figure of $6,368,283.35. The transaction is recorded with Fidelity Brokerage Services LLC and lists 06/02/2026 and NYSE as venue details.
Sharma Ruby reported acquisition or exercise transactions in this Form 4 filing.
ATI Inc. director Ruby Sharma received a grant of 905 shares of common stock as part of the company’s director compensation program. The award, issued under ATI’s 2022 Incentive Plan, carries no cash purchase price and will vest on the first anniversary of the grant date. Following this equity award, Sharma directly holds 7,285 shares of ATI common stock. This is a routine, compensation-related stock grant rather than an open-market purchase or sale.
Morehouse David J reported acquisition or exercise transactions in this Form 4 filing.
ATI INC director David J. Morehouse received an annual equity award of 1,743 shares of common stock as part of the company’s director compensation program. The grant is in the form of restricted stock under ATI’s 2022 Incentive Plan and carries no cash purchase price. The award will vest on the first anniversary of the grant date. Following this grant, Morehouse directly holds a total of 38,311 ATI common shares.
Lydon-Rodgers Jean reported acquisition or exercise transactions in this Form 4 filing.
ATI Inc director Jean Lydon-Rodgers received a grant of 905 shares of common stock as part of the company’s director compensation program. The award is structured as restricted stock under ATI’s 2022 Incentive Plan and carries a grant price of $0.00 per share.
The restricted shares vest on the first anniversary of the grant date, meaning they are earned over time rather than immediately. Following this award, Lydon-Rodgers directly holds a total of 1,536 ATI common shares.
ATI Inc director Elizabeth Hefley Lund reported an acquisition of 905 shares of common stock. This was an annual award of restricted stock granted under ATI’s 2022 Incentive Plan as part of the director compensation program, with the award vesting on the first anniversary of the grant date. Following the grant, she holds 1,536 shares of ATI common stock directly.
Kah Marianne reported acquisition or exercise transactions in this Form 4 filing.
ATI Inc. director Marianne Kah received an annual grant of 905 shares of common stock as part of the company’s director compensation program. The restricted stock was granted under ATI’s 2022 Incentive Plan and will vest on the first anniversary of the grant date. Following this award, Kah directly holds a total of 35,075 ATI common shares.
Hess David P reported acquisition or exercise transactions in this Form 4 filing.
ATI Inc director David P. Hess received an annual equity grant of 905 shares of common stock as a restricted stock award. The grant was made under ATI’s 2022 Incentive Plan as part of the director compensation program and carries a grant price of $0.00 per share.
The award vests on the first anniversary of the grant date. Following this grant, Hess directly holds a total of 34,945 ATI common shares.